Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01754324 · ClinicalTrials.gov registry record

The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome

A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
20
Enrollment target

NCT01754324 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01754324 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The chronic use of opiate medications during pregnancy is a major public health challenge. Prolonged exposure to opiates in utero may result in withdrawal symptoms in infants commonly referred to as neonatal abstinence syndrome (NAS). Signs of NAS may include irritability, high-pitched crying, muscle tightness, seizures, diarrhea, vomiting, poor feeding, and unstable body temperature. Many infants may be treated by supportive (non-pharmacological) therapy by minimizing stimulation, cuddling, responding promptly to hunger cues, and other comfort care. However, some infants continue to show severe symptoms of withdrawal despite these interventions. In these cases, infants may be treated with medications (pharmacological therapy). Although it has been several decades since the first descriptions of NAS, there still remains limited information with regards to the most effective treatment. We hypothesize that medical treatment protocols of NAS with methadone can be optimized by better understanding what the body does to the drug (the population-based pharmacokinetics of methadone).

Interventions

  • DRUG Methadone

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-12
Est. Completion 2013-12

What the Registry Record Tells You About NCT01754324

The ClinicalTrials.gov registry entry for NCT01754324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Methadone is the first listed.

NCT01754324 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01754324 about?

NCT01754324 is a clinical study titled "The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome". The chronic use of opiate medications during pregnancy is a major public health challenge. Prolonged exposure to opiates in utero may result in withdrawal symptoms in infants commonly referred to as neonatal abstinence syndrome (NAS). Signs of NAS may include irritability, high-pitched crying, muscl...

What is the current status of trial NCT01754324?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-12. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01754324?

The interventions under investigation include: Methadone (DRUG).

Who is sponsoring clinical trial NCT01754324?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.